JOURNAL OF CATARACT AND REFRACTIVE SURGERY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1200586, encodeId=d8b412005862b, content=投稿命中率:25.0 经验分享：with editor 2月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=030d4059821, createdName=wangyani_2008_225, createdTime=Tue Mar 08 16:05:58 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092677, encodeId=f15110926e788, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092678, encodeId=773910926e8e2, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538939, encodeId=4b4653893983, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511495, encodeId=0dfb511495db, content=审稿速度:2.0 经验分享：sci处女作就是献给这份杂志，写的是白内障手法手术的改良技术，写得很认真，不上班写了半个月吧才写好，没有请任何人给润色。投稿后杂志社严格按照说好的时间8周给了审稿意见，小修，认真回复了马上被接受了。简直不敢相信！但也就是第一次的无比顺利给了我错觉，以为我的SCI之路将会是通畅的大道。没想到继续投同一系列的文章就再也没有中过。毕竟手法白内障在发达国家几乎没有市场了。反过来看当初能中这个专业最高级别的杂志真是极其幸运的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df6e1623051, createdName=zengyuan43, createdTime=Mon Apr 27 22:21:00 CST 2015, time=2015-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477347, encodeId=667c4e7347e4, content=偏重的研究方向：外科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322028911, createdName=zixizhuangyuan, createdTime=Tue Jun 28 15:59:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2022-03-08 wangyani_2008_225

投稿命中率:25.0
经验分享：with editor 2月没有消息

104 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1200586, encodeId=d8b412005862b, content=投稿命中率:25.0 经验分享：with editor 2月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=030d4059821, createdName=wangyani_2008_225, createdTime=Tue Mar 08 16:05:58 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092677, encodeId=f15110926e788, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092678, encodeId=773910926e8e2, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538939, encodeId=4b4653893983, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511495, encodeId=0dfb511495db, content=审稿速度:2.0 经验分享：sci处女作就是献给这份杂志，写的是白内障手法手术的改良技术，写得很认真，不上班写了半个月吧才写好，没有请任何人给润色。投稿后杂志社严格按照说好的时间8周给了审稿意见，小修，认真回复了马上被接受了。简直不敢相信！但也就是第一次的无比顺利给了我错觉，以为我的SCI之路将会是通畅的大道。没想到继续投同一系列的文章就再也没有中过。毕竟手法白内障在发达国家几乎没有市场了。反过来看当初能中这个专业最高级别的杂志真是极其幸运的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df6e1623051, createdName=zengyuan43, createdTime=Mon Apr 27 22:21:00 CST 2015, time=2015-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477347, encodeId=667c4e7347e4, content=偏重的研究方向：外科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322028911, createdName=zixizhuangyuan, createdTime=Tue Jun 28 15:59:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2021-12-28 Mia

摘要一定要描述使用的方法么？

78 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1200586, encodeId=d8b412005862b, content=投稿命中率:25.0 经验分享：with editor 2月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=030d4059821, createdName=wangyani_2008_225, createdTime=Tue Mar 08 16:05:58 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092677, encodeId=f15110926e788, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092678, encodeId=773910926e8e2, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538939, encodeId=4b4653893983, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511495, encodeId=0dfb511495db, content=审稿速度:2.0 经验分享：sci处女作就是献给这份杂志，写的是白内障手法手术的改良技术，写得很认真，不上班写了半个月吧才写好，没有请任何人给润色。投稿后杂志社严格按照说好的时间8周给了审稿意见，小修，认真回复了马上被接受了。简直不敢相信！但也就是第一次的无比顺利给了我错觉，以为我的SCI之路将会是通畅的大道。没想到继续投同一系列的文章就再也没有中过。毕竟手法白内障在发达国家几乎没有市场了。反过来看当初能中这个专业最高级别的杂志真是极其幸运的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df6e1623051, createdName=zengyuan43, createdTime=Mon Apr 27 22:21:00 CST 2015, time=2015-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477347, encodeId=667c4e7347e4, content=偏重的研究方向：外科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322028911, createdName=zixizhuangyuan, createdTime=Tue Jun 28 15:59:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2021-12-28 Mia

摘要中一定要加入研究目标么？

98 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1200586, encodeId=d8b412005862b, content=投稿命中率:25.0 经验分享：with editor 2月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=030d4059821, createdName=wangyani_2008_225, createdTime=Tue Mar 08 16:05:58 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092677, encodeId=f15110926e788, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092678, encodeId=773910926e8e2, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538939, encodeId=4b4653893983, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511495, encodeId=0dfb511495db, content=审稿速度:2.0 经验分享：sci处女作就是献给这份杂志，写的是白内障手法手术的改良技术，写得很认真，不上班写了半个月吧才写好，没有请任何人给润色。投稿后杂志社严格按照说好的时间8周给了审稿意见，小修，认真回复了马上被接受了。简直不敢相信！但也就是第一次的无比顺利给了我错觉，以为我的SCI之路将会是通畅的大道。没想到继续投同一系列的文章就再也没有中过。毕竟手法白内障在发达国家几乎没有市场了。反过来看当初能中这个专业最高级别的杂志真是极其幸运的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df6e1623051, createdName=zengyuan43, createdTime=Mon Apr 27 22:21:00 CST 2015, time=2015-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477347, encodeId=667c4e7347e4, content=偏重的研究方向：外科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322028911, createdName=zixizhuangyuan, createdTime=Tue Jun 28 15:59:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2017-07-18 med_wu

过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。

346 0

[GetPortalCommentsPageByObjectIdResponse(id=1200586, encodeId=d8b412005862b, content=投稿命中率:25.0 经验分享：with editor 2月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=030d4059821, createdName=wangyani_2008_225, createdTime=Tue Mar 08 16:05:58 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092677, encodeId=f15110926e788, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092678, encodeId=773910926e8e2, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538939, encodeId=4b4653893983, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511495, encodeId=0dfb511495db, content=审稿速度:2.0 经验分享：sci处女作就是献给这份杂志，写的是白内障手法手术的改良技术，写得很认真，不上班写了半个月吧才写好，没有请任何人给润色。投稿后杂志社严格按照说好的时间8周给了审稿意见，小修，认真回复了马上被接受了。简直不敢相信！但也就是第一次的无比顺利给了我错觉，以为我的SCI之路将会是通畅的大道。没想到继续投同一系列的文章就再也没有中过。毕竟手法白内障在发达国家几乎没有市场了。反过来看当初能中这个专业最高级别的杂志真是极其幸运的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df6e1623051, createdName=zengyuan43, createdTime=Mon Apr 27 22:21:00 CST 2015, time=2015-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477347, encodeId=667c4e7347e4, content=偏重的研究方向：外科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322028911, createdName=zixizhuangyuan, createdTime=Tue Jun 28 15:59:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2015-04-27 zengyuan43

审稿速度:2.0
经验分享：sci处女作就是献给这份杂志，写的是白内障手法手术的改良技术，写得很认真，不上班写了半个月吧才写好，没有请任何人给润色。投稿后杂志社严格按照说好的时间8周给了审稿意见，小修，认真回复了马上被接受了。简直不敢相信！但也就是第一次的无比顺利给了我错觉，以为我的SCI之路将会是通畅的大道。没想到继续投同一系列的文章就再也没有中过。毕竟手法白内障在发达国家几乎没有市场了。反过来看当初能中这个专业最高级别的杂志真是极其幸运的。

365 0

[GetPortalCommentsPageByObjectIdResponse(id=1200586, encodeId=d8b412005862b, content=投稿命中率:25.0 经验分享：with editor 2月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=030d4059821, createdName=wangyani_2008_225, createdTime=Tue Mar 08 16:05:58 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092677, encodeId=f15110926e788, content=摘要一定要描述使用的方法么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092678, encodeId=773910926e8e2, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538939, encodeId=4b4653893983, content=过去不错的，现在这么跌下去，很吓人。明年想再回到3分水平，也许真心太难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=med_wu, createdTime=Tue Jul 18 18:23:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=511495, encodeId=0dfb511495db, content=审稿速度:2.0 经验分享：sci处女作就是献给这份杂志，写的是白内障手法手术的改良技术，写得很认真，不上班写了半个月吧才写好，没有请任何人给润色。投稿后杂志社严格按照说好的时间8周给了审稿意见，小修，认真回复了马上被接受了。简直不敢相信！但也就是第一次的无比顺利给了我错觉，以为我的SCI之路将会是通畅的大道。没想到继续投同一系列的文章就再也没有中过。毕竟手法白内障在发达国家几乎没有市场了。反过来看当初能中这个专业最高级别的杂志真是极其幸运的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df6e1623051, createdName=zengyuan43, createdTime=Mon Apr 27 22:21:00 CST 2015, time=2015-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477347, encodeId=667c4e7347e4, content=偏重的研究方向：外科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322028911, createdName=zixizhuangyuan, createdTime=Tue Jun 28 15:59:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2011-06-28 zixizhuangyuan

偏重的研究方向：外科;

523 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务